TY - JOUR
T1 - A case of palmoplantar pustulosis induced by certolizumab pegol
T2 - New anti-TNF-alpha demonstrates the same class effect
AU - Shelling, Michael L.
AU - Vitiello, Magalys
AU - Lanuti, Emma L.
AU - Miteva, Maria
AU - Romanelli, Paolo
AU - Kerdel, Francisco A.
PY - 2012/8/1
Y1 - 2012/8/1
N2 - The development of de novo psoriasis in patients treated with tumor necrosis factor-alpha antagonists is well recognized. The authors hereby report a case of palmplantar pustular psoriasis in a patient with rheumatoid arthritis treated with etanercept. The condition responded to topical steroids but re-occurred upon treating the patient with certolizumab pegol. This strongly suggests that the development of de novo psoriasis is a class effect.
AB - The development of de novo psoriasis in patients treated with tumor necrosis factor-alpha antagonists is well recognized. The authors hereby report a case of palmplantar pustular psoriasis in a patient with rheumatoid arthritis treated with etanercept. The condition responded to topical steroids but re-occurred upon treating the patient with certolizumab pegol. This strongly suggests that the development of de novo psoriasis is a class effect.
UR - http://www.scopus.com/inward/record.url?scp=84866255897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866255897&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84866255897
VL - 5
SP - 40
EP - 41
JO - Journal of Clinical and Aesthetic Dermatology
JF - Journal of Clinical and Aesthetic Dermatology
SN - 1941-2789
IS - 8
ER -